Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics' Preliminary 2013 Revenues Improve 60 Percent

NEW YORK (GenomeWeb News) – Epigenomics today announced preliminary revenue growth of 60 percent for full-year 2013.

Revenues for 2013 increased to €1.6 million ($2.2 million) from €1.0 million in 2012 on a strategic collaboration with BioChain in China and increased R&D service fees, the firm said.

Epigenomics' net loss for the year shrank to €7.4 million, or €.62 per share, from a net loss of €12.2 million, or €1.38 per share, in 2012.

Its R&D costs were reduced 45 percent year over year to €4.4 million from €8.0 million, and its SG&A spending was cut 18 percent to €4.5 million from €5.5 million.

Epigenomics currently is awaiting a decision from the US Food and Drug Administration on its premarket approval submission for the company's Epi proColon blood-based colorectal cancer screening test and is scheduled to meet with an FDA panel next month.

In a statement, Epigenomics CEO and CFO Thomas Taapken said that work toward getting FDA approval "clearly determined our efforts over the past year. During 2013, we successfully established a framework of partnerships in order to commercialize the product following potential regulatory approval in the US and to develop new markets, for example, China. Lastly, we improved our financial position, after raising €12.5 million in 2013."

Epigenomics ended the year with €7.2 million in cash and cash equivalents. Including marketable securities, its total liquidity at the end of 2013 was €8.0 million, which should give the company "enough buffer time to be fully operational until the expected FDA approval for Epi proColon, probably in the second quarter of 2014, and possibly beyond," Epigenomics said.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.